Connecting you to content on EBSCOhost

Works matching DE "NOVARTIS Pharmaceuticals Corp."

Results: 65

1

A phase II trial of imatinib mesylate in patients with biochemical relapse of prostate cancer after definitive local therapy.

Published in:

BJU International, 2006, v. 98, n. 4, p. 763, doi. 10.1111/j.1464-410X.2006.06396.x

By:

Lin, Amy M.;
Rini, Brian I.;
Weinberg, Vivian;
Fong, Kristen;
Ryan, Charles J.;
Rosenberg, Jonathan E.;
Fong, Lawrence;
Small, Eric J.

Publication type:

Article

2

New Treatment for Chronic Myelogenous Leukemia.

Published in:

JAMA: Journal of the American Medical Association, 2001, v. 286, n. 1, p. 35, doi. 10.1001/jama.286.1.35

By:

Schwetz, Bernard A.

Publication type:

Article

3

Terbinafine Hydrochloride in Ethanol Effectively Clears Batrachochytrium dendrobatidis in Amphibians.

Published in:

Journal of Herpetological Medicine & Surgery, 2010, v. 20, n. 1, p. 24, doi. 10.5818/1529-9651-20.1.24

By:

Bowerman, Jay;
Rombough, Chris;
Weinstock, Sarah R.;
Padgett-Flohr, Gretchen E.

Publication type:

Article

4

Demise of the life science company begins.

Published in:

Nature Biotechnology, 2000, v. 18, n. 1, p. 14, doi. 10.1038/71841

By:

Niiler, Eric

Publication type:

Article

5

Isis and antisense face crucial test without Novartis.

Published in:

Nature Biotechnology, 2000, v. 18, n. 1, p. 19, doi. 10.1038/71852

By:

Dove, Alan

Publication type:

Article

6

Fingolimod hydrochloride.

Published in:: 2011
Publication type:: Product Review

7

Euro tie-up.

Published in:: Nature, 2007, v. 450, n. 7172, p. 935, doi. 10.1038/450935a
Publication type:: Article

8

Two oral drugs for MS show promise.

Published in:: Inside MS, 2005, v. 23, n. 6, p. 32
Publication type:: Article

9

Amicus Briefs.

Published in:: Defense Counsel Journal, 2017, v. 84, n. 1, p. 7
Publication type:: Article

10

actions in brief.

Published in:: Formulary, 2007, v. 42, n. 12, p. 662
Publication type:: Article

11

SPONSORS.

Published in:: Nephrology, 2007, v. 12, p. vi, doi. 10.1111/j.1440-1797.2007.00849_3.x
Publication type:: Article

12

SPONSORS OF AWARDS AT THE ANNUAL SCIENTIFIC MEETING.

Published in:: Nephrology, 2007, v. 12, p. vi, doi. 10.1111/j.1440-1797.2007.00849_4.x
Publication type:: Article

13

SPONSORS.

Published in:: Nephrology, 2006, v. 11, p. iv, doi. 10.1111/j.1440-1797.2006.00658_2.x
Publication type:: Article

14

Implementation of and experiences with new automation.

Published in:

Journal of Automated Methods & Management in Chemistry, 2000, v. 22, n. 6, p. 199, doi. 10.1080/146392400750041077

By:

Mahmud, Ifte;
Kim, David

Publication type:

Article

15

Nilotinib: A Review of its Use in Chronic Myelogenous Leukemia.

Published in:

Clinical Medicine Insights: Therapeutics, 2010, n. 2, p. 841, doi. 10.4137/CMT.S24

By:

Ting-Wei Lu;
Swords, Ronan;
Giles, Francis J.;
Kevin Kelly

Publication type:

Article

16

News update.

Published in:: Applied Clinical Trials, 2000, v. 9, n. 3, p. 12
Publication type:: Article

17

U.S. Food and Drug Administration (FDA) Approves Exelon.

Published in:: American Journal of Alzheimer's Disease & Other Dementias, 2007, v. 22, n. 2, p. 146
Publication type:: Article

18

Osta Announces Approval of Exelon.

Published in:: American Journal of Alzheimer's Disease & Other Dementias, 2006, v. 21, n. 5, p. 367
Publication type:: Article

19

From the FDA.

Published in:: Brown University Psychopharmacology Update, 2005, v. 16, n. 8, p. 8
Publication type:: Article

20

ESOT - Novartis Study Grant: Call for Application, Guidelines and Application Form.

Published in:: Transplant International, 2004, v. 17, n. 6, p. 339, doi. 10.1007/s00147-004-0730-7
Publication type:: Article

21

Bioequivalence Study of Vildagliptin and Metformin Fixed Dose Combinations in Healthy Volunteers.

Published in:

Indian Practitioner, 2019, v. 72, n. 12, p. 21

By:

Mungantiwar, Ashish;
Sen, Pratip;
Ambekar, Shalmali;
Agarwal, Rajendra

Publication type:

Article

22

Differential Pharmacological Effects of Antimuscarinic Drugs on Heart Rate: A Randomized, Placebo-controlled, Double-blind, Crossover Study With Tolterodine and Darifenacin in Healthy Participants ≥50 Years.

Published in:: Journal of Cardiovascular Pharmacology & Therapeutics, 2008, v. 13, n. 4, p. 241, doi. 10.1177/1074248408325404
Publication type:: Article

23

The Magic of Modern Medicine: A Dilemma for Dentistry?

Published in:

2006

By:

Konzelman Jr., Joseph L.;
Herman, Wayne W.

Publication type:

Editorial

24

Aromatase Inhibitors and Musculoskeletal Pain in Patients With Breast Cancer.

Published in:

Clinical Journal of Oncology Nursing, 2007, v. 11, n. 3, p. 433, doi. 10.1188/07.CJON.433-439

By:

Winters, Loren;
Habin, Karleen;
Gallagher, Joan

Publication type:

Article

25

Overview of Second-Generation Tyrosine Kinase Inhibitors for Patients With Imatinib-Resistant Chronic Myelogenous Leukemia.

Published in:

Clinical Journal of Oncology Nursing, 2007, v. 11, n. 1, p. 125, doi. 10.1188/07.CJON.125-129

By:

Ault, Patricia

Publication type:

Article

26

Letrozole (Femara).

Published in:

Clinical Journal of Oncology Nursing, 2004, v. 8, n. 3, p. 314, doi. 10.1188/04.CJON.314-315

By:

Gerken, Patty;
Lindemann, Karen

Publication type:

Article

27

FDA Approves New Drug for Gastrointestinal Stromal Tumors.

Published in:

Clinical Journal of Oncology Nursing, 2002, v. 6, n. 3, p. 124

By:

Cope, Diane

Publication type:

Article

28

Keep Your Eye On...

Published in:: Brown University Child & Adolescent Behavior Letter, 2001, v. 17, n. 5, p. 2
Publication type:: Article

29

MARKETPLACE: Drug & therapeutics update.

Published in:: Oncology Exchange, 2012, v. 11, n. 3, p. 47
Publication type:: Article

30

IP Case Law Developments.

Published in:

Journal of Intellectual Property Rights, 2007, v. 12, n. 5, p. 507

By:

Thomas, Zakir

Publication type:

Article

31

NEW PRODUCTS.

Published in:: Contemporary OB/GYN, 2009, v. 54, n. 10, p. 42
Publication type:: Article

32

Forecasting the Future for Pharma.

Published in:

Bio-IT World, 2004, v. 3, n. 1, p. 27

By:

Smyth, Simon

Publication type:

Article

33

Talent Fuels Drug Pipeline in Swiss Time.

Published in:

Bio-IT World, 2003, v. 2, n. 1, p. 63

By:

Dodge, John

Publication type:

Article

34

Bio-IT Innovators.

Published in:: Bio-IT World, 2003, v. 2, n. 1, p. 35
Publication type:: Article

35

Fingolimod (FTY720): First approved oral therapy for multiple sclerosis.

Published in:

Journal of Pharmacology & Pharmacotherapeutics, 2011, v. 2, n. 1, p. 49, doi. 10.4103/0976-500X.77118

By:

Sharma, Sushil;
Mathur, A. G.;
Pradhan, Sapna;
Singh, D. B.;
Gupta, Sparsh

Publication type:

Article

36

FDA approves new quadrivalent meningococcal vaccine.

Published in:

American Journal of Health-System Pharmacy, 2010, v. 67, n. 7, p. 504, doi. 10.2146/news100023

By:

Thompson, Cheryl A.

Publication type:

Article

37

News Briefs.

Published in:: American Journal of Health-System Pharmacy, 2006, v. 63, n. 23, p. 2306, doi. 10.1093/ajhp/63.23.2306
Publication type:: Article

38

Co-administering diclofenac with intravenous paracetamol or Hartmann's solution.

Published in:

Anaesthesia, 2014, v. 69, n. 2, p. 191, doi. 10.1111/anae.12578

By:

Madden, G. B. P.

Publication type:

Article

39

Prescribing Update.

Published in:

Patient Care (Print), 2002, v. 36, n. 5, p. 17

By:

LoBuono, Charlotte

Publication type:

Article

40

A new heart failure study.

Published in:: Patient Care (Print), 1997, v. 31, n. 17, p. 11
Publication type:: Article

41

Novartis announce new therapeutic indication for Lucentis®.

Published in:: 2011
Publication type:: Product Review

42

Novartis, Alnylam team up again.

Published in:

Chemistry & Industry, 2006, n. 5, p. 5

By:

Dorey, Emma

Publication type:

Article

43

Novartis and Alnylam collaborate to develop new RNAi drug.

Published in:

Chemistry & Industry, 2005, n. 18, p. 8

By:

Dorey, Emma

Publication type:

Article

44

Novartis signs $375m drug.

Published in:

Chemistry & Industry, 2005, n. 9, p. 6

By:

Eisberg, Neil

Publication type:

Article

45

Eye drops may prevent short-sightedness.

Published in:: Chemistry & Industry, 2003, n. 2, p. 8
Publication type:: Article

46

IBS-Drug Treatment Pulled, CV Side Effects.

Published in:

OB/GYN Clinical Alert, 2007, v. 24, n. 1, p. 1

By:

Elliott, William T.

Publication type:

Article

47

Migraine drug recalled.

Published in:

Canadian Medical Association Journal (CMAJ), 2001, v. 164, n. 9, p. 1336

By:

CMAJ

Publication type:

Article

48

New Products & Services.

Published in:: Urology Times, 2004, v. 32, n. 6, p. 32
Publication type:: Article

49

OAB drug receives approvable letter.

Published in:: Urology Times, 2003, v. 31, n. 11, p. 39
Publication type:: Article

50

Update on the use of ciclosporin in immune-mediated dermatoses.

Published in:: Current Medical Literature: Dermatology, 2006, v. 11, n. 4, p. 98
Publication type:: Article